T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. - Wikidata - wikimedia - TriplyDB

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

http://www.wikidata.org/entity/Q37143961

about

Immunologic changes in frail older adults A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood.Coagulation and autoimmunity in scleroderma interstitial lung disease.Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis.A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma Vascular disease in scleroderma.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives Circulating biomarkers of interstitial lung disease in systemic sclerosis.Fibroblast autophagy in fibrotic disorders.The evolving pharmacotherapy of pulmonary fibrosis.The role of the acquired immune response in systemic sclerosis.Potential roles of interleukin-17A in the development of skin fibrosis in mice.Multiparameter flow cytometry for discovery of disease mechanisms in rheumatic diseases.A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials.Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience.GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production.Regulatory T Cells in Systemic Sclerosis

P2860

Q26866941-C9B6FF3F-EF58-467C-90FE-AA905A89A21A Q30993697-D11599A5-3ED5-4E71-AFCD-B5B9C9322DDA Q33736823-67B9497C-F42D-4A5F-AA71-EE4CA33FC196 Q34231085-0E14EEF4-13E8-4B64-8255-7376F94C619C Q34344620-B74F1081-BEA1-43D2-911A-3BC0E3B97D2E Q34770486-8E5CFC2A-DBDD-43F1-97FB-0D7525BC5D0A Q35566387-F02C104A-5CF5-4B69-894B-2A77683FB82E Q35816882-9862AF93-ADB7-465B-9184-B1AA13FCF822 Q36871425-92B58596-24A8-43CB-8C12-E2E80BDBEE09 Q37344793-0D9D060A-735A-4D57-BA3D-B66AA997BE1E Q37381549-BE342D1F-3F2D-41BE-97CA-B48CEA177280 Q38044387-C8A90400-23C7-4B97-9A2D-7E8C2698AE11 Q38047232-9379219E-021A-4DB3-8026-C6470AF2B6E1 Q38069617-CE64BA70-8ADB-4C6B-8498-C6FD51662AE4 Q38543690-D7DA3ADE-00FD-49C9-B7FB-C5358A548BAE Q39308063-45BF3575-1CA2-427F-BE32-71AA38DC93C2 Q40107170-FC6A7555-E936-4DBD-8ADD-D9CFB3EE1679 Q44506483-403E4CB1-FE87-4395-AF76-794B62C2F824 Q46145863-2014052E-55DA-43B8-88DA-DE48775194A5 Q52976551-4BE845F3-9B5E-491C-942B-0E8668557A95 Q54367655-3504C061-14DE-42CE-BB72-F5B083CB2BC8 Q58122062-E2E96705-19F0-4A99-A038-A3F61A41124E

P2860

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

http://www.wikidata.org/entity/Q37143961

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

@en

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

@nl

type

label

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

@en

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

@nl

prefLabel

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

@en

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

@nl

P1433

Q37143961-C1BFCEA6-9ECA-491F-8AC5-6D9F7102E86D

P1476

Q37143961-11AE00FC-76C9-4970-BD4B-FCB7FF3CD5F2

P2093

Q37143961-239C5FBF-3DB5-4F20-AA3B-C2D8C19F48D9

Q37143961-49FE8D58-EF69-4F05-9F05-F76419B469C8

Q37143961-69929DC9-0BC5-47F4-A14C-3FAE2B8B35DA

Q37143961-D14C3999-9EAF-44C7-915B-7C5C42D33487

P2860

Q37143961-0319B8D0-8E64-40B3-A526-2771ED830B3A

Q37143961-0DFF2412-6FC7-452F-8D55-3A5471CC1854

Q37143961-2260AB5C-CF20-496A-906C-610885F704BC

Q37143961-422AC94A-AC58-4C11-8664-C2151AEB5736

Q37143961-53779A75-1D63-468B-A5AC-57E40CFFB0D7

Q37143961-598E45AC-FB54-491E-BE52-9797A6740609

Q37143961-5AEB9D7D-0D24-4F1E-96E1-04342668E555

Q37143961-5C236C4C-9610-4427-BC4A-BBDAFBDD090D

Q37143961-632B9C83-ED2F-4A7D-AEC6-4F06B58719EF

Q37143961-63A989DC-693D-4955-9670-21255AC66D2E

P304

Q37143961-52A64C3E-DCAF-42C1-9E4A-5AD43BA7CE36

P31

Q37143961-F38C912C-3F2A-4E48-9AA1-B195043B476A

P356

Q37143961-AA6B1275-FA3C-4FC1-91C7-90811B5A1E2D

P433

Q37143961-A04A5629-B358-4FA3-BB61-5F646E7EC4C0

P478

Q37143961-B27A19B6-412A-4069-959A-9C4E26AC02B5

P50

Q37143961-20136775-2D90-4FF1-9677-0CF146001472

Q37143961-5BEC19C5-A05F-4257-AC4E-A8A74A213F9E

P577

Q37143961-F376531E-5F40-4970-BEFA-FE94A24F6EF7

P5875

Q37143961-1EF294D9-70D3-433E-AAA8-4940AEFAEC1B

P698

Q37143961-C885A560-9BCF-4519-BCCD-B268F14D0BE5

P932

Q37143961-797BF6F4-D356-4BE7-B00A-7BCDC24BAF5F

P356

P1433

Arthritis and Rheumatism

P1476

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease

@en

P2093

Antony Rosen

http://www.w3.org/2001/XMLSchema#string

Francesco Boin

http://www.w3.org/2001/XMLSchema#string

Fredrick M Wigley

http://www.w3.org/2001/XMLSchema#string

Umberto De Fanis

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Mortality in systemic sclerosis: an international meta-analysis of individual patient data.

The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit.

Criteria for the classification of early systemic sclerosis.

Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression.

The Th1/Th2 paradigm.

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.

GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells.

The immunobiology of Th1 polarization in high-pathology schistosomiasis.

P304

1165-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.23406

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Susan J. Bartlett

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5470071

http://www.w3.org/2001/XMLSchema#string

P698

18383361

http://www.w3.org/2001/XMLSchema#string

P932

2662772

http://www.w3.org/2001/XMLSchema#string